Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 11794
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648435(US20240033264, Example 1)
Affinity DataIC50: 10nMAssay Description:The CDK4 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648435(US20240033264, Example 1)
Affinity DataIC50: 10nMAssay Description:The CDK6 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648436(US20240033264, Example 2)
Affinity DataIC50: 10nMAssay Description:The CDK4 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648437(US20240033264, Example 3)
Affinity DataIC50: 10nMAssay Description:The CDK4 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648437(US20240033264, Example 3)
Affinity DataIC50: 10nMAssay Description:The CDK6 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648437(US20240033264, Example 3)
Affinity DataIC50: 10nMAssay Description:The CDK2 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648438(US20240033264, Example 4)
Affinity DataIC50: 10nMAssay Description:The CDK4 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648435(US20240033264, Example 1)
Affinity DataIC50: 100nMAssay Description:The CDK2 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648436(US20240033264, Example 2)
Affinity DataIC50: 100nMAssay Description:The CDK6 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648436(US20240033264, Example 2)
Affinity DataIC50: 100nMAssay Description:The CDK2 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648438(US20240033264, Example 4)
Affinity DataIC50: 100nMAssay Description:The CDK6 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM648438(US20240033264, Example 4)
Affinity DataIC50: 1.00E+3nMAssay Description:The CDK2 enzyme assay for IC50 determination was performed as follows. Microfluidic kinase detection technology (Caliper) was used to monitor the pho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
Go to US Patent